Array
(
    [0] => Implement T2D guidelines in the selection of individualized treatment approaches

    [1] => Discuss the pathophysiology of T2D and the role of different classes of glucose-lowering agents in addressing the various aspects of T2D pathophysiology

    [2] => Describe similarities and differences between GLP-1 RAs in terms of glycemic management, weight effects, side effects, and cardiovascular/renal benefits

    [3] => Apply current evidence in the individualized selection of GLP-1 RAs to those with T2D
)